OH; SangKon

Patent Applications and Registrations

Patent applications and USPTO patent grants for OH; SangKon.The latest application filed is for "agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)".

Company Profile

12.32.46

OH; SangKon - Baltimore MD
Oh; Sangkon - Dallas TX US
Oh; SangKon - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20220152192 - OH; SangKon ; et al.	2022-05-19
Nucleic acids encoding anti-CD40 antibodies Grant 11,267,895 - Banchereau , et al. March 8, 2	2022-03-08
Dendritic Cell Asgpr Targeting Immunotherapeutics For Multiple Sclerosis App 20220054609 - OH; SangKon ; et al.	2022-02-24
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 11,173,202 - Oh , et al. November 16, 2	2021-11-16
Fusion Proteins Comprising An Anti-cd40 Antibody And Cancer Antigens App 20210308242 - ZURAWSKI; Gerard ; et al.	2021-10-07
Methods and Compositions for Treating Autoimmune and Inflammatory Conditions App 20210299224 - OH; SangKon ; et al.	2021-09-30
Novel Vaccines Against Hpv And Hpv-related Diseases App 20210268097 - OH; SangKon ; et al.	2021-09-02
Methods and compositions for treating autoimmune and inflammatory conditions Grant 10,993,990 - Oh , et al. May 4, 2	2021-05-04
Fusion proteins comprising an anti-CD40 antibody and cancer antigens Grant 10,980,869 - Zurawski , et al. April 20, 2	2021-04-20
Vaccines against HPV and HPV-related diseases Grant 10,940,195 - Oh , et al. March 9, 2	2021-03-09
Anti-cd40 Antibodies And Uses Thereof App 20210024641 - Banchereau; Jacques F. ; et al.	2021-01-28
Anti-CD40 antibodies Grant 10,683,361 - Banchereau , et al.	2020-06-16
Antagonistic anti-OX40L antibodies and methods of their use Grant 10,570,208 - Liu , et al. Feb	2020-02-25
Novel Vaccines Against Hpv And Hpv-related Diseases App 20190314481 - OH; SangKon ; et al.	2019-10-17
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20190231865 - OH; SangKon ; et al.	2019-08-01
Vaccines against HPV and HPV-related diseases Grant 10,286,058 - Oh , et al.	2019-05-14
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 10,279,030 - Oh , et al.	2019-05-07
Antagonistic Anti-ox40l Antibodies And Methods Of Their Use App 20190092869 - Liu; Yong-Jun ; et al.	2019-03-28
Anti-cd40 Antibodies And Uses Thereof App 20190085088 - Banchereau; Jacques F. ; et al.	2019-03-21
Antagonistic anti-OX40L antibodies and methods of their use Grant 10,167,339 - Liu , et al. J	2019-01-01
Method of making an anti-CD40 antibody Grant 10,087,256 - Banchereau , et al. October 2, 2	2018-10-02
Antigen Presenting Cell Targeted Cancer Vaccines App 20180000916 - Zurawski; Gerard ; et al.	2018-01-04
Antagonistic Anti-ox40l Antibodies And Methods Of Their Use App 20170349661 - LIU; Yong-Jun ; et al.	2017-12-07
Anti-cd40 Antibodies And Uses Thereof App 20170114142 - Banchereau; Jacques F. ; et al.	2017-04-27
Methods and Compositions for Treating Autoimmune and Inflammatory Conditions App 20170106051 - Oh; SangKon ; et al.	2017-04-20
Methods And Compositions For Treating Allergy And Inflammatory Diseases App 20170095573 - OH; SangKon ; et al.	2017-04-06
Anti-CD40 antibodies Grant 9,567,401 - Banchereau , et al. February 14, 2	2017-02-14
Anti-CD40 antibodies Grant 9,562,104 - Banchereau , et al. February 7, 2	2017-02-07
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20160375126 - Oh; SangKon ; et al.	2016-12-29
Novel Vaccines Against Hpv And Hpv-related Diseases App 20160331825 - OH; SangKon ; et al.	2016-11-17
Dendritic Cell Asgpr Targeting Immunotherapeutics For Multiple Sclerosis App 20160296609 - Oh; SangKon ; et al.	2016-10-13
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 9,453,074 - Oh , et al. September 27, 2	2016-09-27
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 9,339,556 - Banchereau , et al. May 17, 2	2016-05-17
Vaccines directed to langerhans cells Grant 9,315,580 - Banchereau , et al. April 19, 2	2016-04-19
Antigen Presenting Cell Targeted Cancer Vaccines App 20160022792 - Zurawski; Gerard ; et al.	2016-01-28
Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Grant 9,109,011 - Banchereau , et al. August 18, 2	2015-08-18
Fusion proteins comprising antibody and HPV E6 and E7 antigens Grant 9,102,734 - Zurawski , et al. August 11, 2	2015-08-11
Immunoadjuvant compounds and uses thereof Grant 9,061,066 - Gorvel , et al. June 23, 2	2015-06-23
Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2) Grant 9,045,542 - Oh , et al. June 2, 2	2015-06-02
Enhancement Of Pathogen-specific Memory Th17 Cell Responses App 20150064205 - Oh; SangKon ; et al.	2015-03-05
Therapeutic Applications Of Activation Of Human Antigen-presenting Cells Through Dectin-1 App 20140322214 - Banchereau; Jacques F. ; et al.	2014-10-30
Anti-cd40 Antibodies And Uses Thereof App 20140234344 - Banchereau; Jacques F. ; et al.	2014-08-21
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20140227268 - Banchereau; Jacques F. ; et al.	2014-08-14
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,728,481 - Banchereau , et al. May 20, 2	2014-05-20
Activation Of Human Antigen-presenting Cells Through Dendritic Cell Lectin-like Oxidized Ldl Receptor-1 (lox-1) App 20140120617 - BANCHEREAU; JACQUES F. ; et al.	2014-05-01
Vaccines Directed To Langerhans Cells App 20140030264 - Banchereau; Jacques F. ; et al.	2014-01-30
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 8,481,314 - Banchereau , et al. July 9, 2	2013-07-09
Novel Immunoadjuvant Compounds And Uses Thereof App 20130129756 - Gorvel; Jean-Pierre ; et al.	2013-05-23
Reprogramming Immune Environment In Breast Cancer Via Dendritic Cells App 20130064855 - Palucka; Anna Karolina ; et al.	2013-03-14
CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2) App 20130052193 - Oh; SangKon ; et al.	2013-02-28
SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONS App 20130017151 - Oh; SangKon ; et al.	2013-01-17
SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES App 20120308578 - Oh; SangKon ; et al.	2012-12-06
Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20120282281 - Banchereau; Jacques F. ; et al.	2012-11-08
Diagnostic and Therapeutic Uses for B Cell Maturation Antigen App 20120213768 - Oh; SangKon ; et al.	2012-08-23
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,236,934 - Banchereau , et al. August 7, 2	2012-08-07
Enhancement of Pathogen-Specific Memory Th17 Cell Responses App 20120128710 - Oh; SangKon ; et al.	2012-05-24
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells App 20120121592 - Oh; SangKon ; et al.	2012-05-17
Immunogenic peptides for the treatment of prostate and breast cancer Grant 8,043,623 - Berzofsky , et al. October 25, 2	2011-10-25
Vaccines Directed To Langerhans Cells App 20110081343 - Banchereau; Jacques F. ; et al.	2011-04-07
Anti-cd40 Antibodies And Uses Thereof App 20100239575 - Banchereau; Jacques F. ; et al.	2010-09-23
Immunogenic Peptides For The Treatment Of Prostate And Breast Cancer App 20090208518 - Berzofsky; Jay A. ; et al.	2009-08-20
Immunogenic peptides for the treatment of prostate and breast cancer Grant 7,541,035 - Berzofsky , et al. June 2, 2	2009-06-02
Activation of Human Antigen-Presenting Cells Through Dendritic Cell Lectin-Like Oxidized LDL Receptor-1 (LOX-1) App 20080267984 - Banchereau; Jacques F. ; et al.	2008-10-30
Activation of Human Antigen-Presenting Cells Through CLEC-6 App 20080254047 - Banchereau; Jacques F. ; et al.	2008-10-16
Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1 App 20080233140 - Banchereau; Jacques F. ; et al.	2008-09-25
Agents That Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20080206262 - Banchereau; Jacques F. ; et al.	2008-08-28
Immunogenic peptides for the treatment of prostate and breast cancer App 20060140967 - Berzofsky; Jay A. ; et al.	2006-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.